Alexion Pharmaceuticals in New Haven Alexion Pharmaceuticals in New Haven Photo: Hearst Connecticut Media File Alexion Pharmaceuticals in New Haven Alexion Pharmaceuticals in New Haven Alexion to begin Phase 3 testing on drug to treat ALS Officials with Alexion Pharmaceuticals, which has a significant research and development presence in New Haven, announced the company will begin Phase 3 testing of one of its existing drugs for use in treating amyotrophic lateral sclerosis, also known as ALS or Lou Gehrigs disease. The study of the drug Ultomiris in treating ALS will begin before the end of March and take place over a 50-week period and evaluate 350 adults. Continue reading →

-- LRRK2 inhibitor DNL201 Phase 1b demonstrated high levels of target and pathway engagement and improvement of lysosomal biomarkers in patients with Parkinsons disease -- LRRK2 inhibitor DNL151 Phase 1 demonstrated high levels of target and pathway engagement and modulation of lysosomal biomarkers in healthy volunteers and continues in an expanded Phase 1b study in patients with Parkinsons disease -- IND submitted for DNL310 (ETV:IDS) for Hunter syndrome, Denalis first clinical submission for a large molecule therapeutic enabled by its Transport Vehicle platform technology -- CTA approved for DNL343, a small molecule activator of EIF2B for ALS and other neurodegenerative diseases -- RIPK1 inhibitor DNL747 Phase 1b trials in Alzheimers and ALS fully enrolled and open label extension in ALS ongoing with data readouts on track for mid-2020 SOUTH SAN FRANCISCO, Calif., Jan. 14, 2020 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. Continue reading →

The pictures in the corridor, just across from the main ball room at Newarks Robert Treat Hotel, captured the martial arts greatness of Kevin Brown Thompson. A Newark native, Thompson mastered three disciplines weapons, forms and fighting and won world championships in each category, an achievement rarely attained. Hes in the Black Belt Hall of Fame, his name and accomplishments listed with legends Bruce Lee and Chuck Norris. Continue reading →

Global Prostacyclin Market Forecast to 2025 is a new research released at Market Study Report and provides information about industry Top Key Players, Countries, Type and Application. This Prostacyclin report also states Company Profile, sales, Prostacyclin Market revenue and price, market share, market growth and gross margin by regions, Strategic recommendations for the new entrants, Market forecasts for a minimum of five years of all the mentioned segments, sub segments and the regional markets. Continue reading →